|
시장보고서
상품코드
2075358
주사 치료제 시장 : 약제 클래스별, 투여 경로별, 유형별, 유통 채널별, 지역별Rosacea Treatment Market, By Drug Class, By Route of Administration, By Type, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
주사 치료제 시장은 2026년에 23억 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 36억 3,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.7%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 23억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2033년) | 6.70% | 예측 금액(2033년) | 36억 3,000만 달러 |
주사는 얼굴의 붉어짐과 화끈거림, 때로는 고름이 동반된 작은 돌기가 나타나는 것이 특징인 만성 피부 질환입니다. 그 관리에 어려움이 따르기도 하지만, 다양한 치료법을 이용할 수 있습니다. 주사 증상을 완화하고 환자의 삶의 질을 향상시키기 위해, 시장에서는 외용약, 내복약, 레이저 치료, 광선 요법, 스킨케어 제품 등 다양한 치료 옵션이 제공되고 있습니다. 주사의 정확한 원인은 밝혀지지 않았으나, 유전적 요인, 환경적 유발 요인, 일부 약물 등 여러 요인이 관여하고 있는 것으로 여겨집니다.
시장 역학 :
인지도 및 진단 건수의 증가는 예측 기간 중 전 세계 주사 치료제 시장의 성장을 지속적으로 견인할 것으로 보입니다. 현재, 환자와 의료 전문가 모두 주사에 대해 더 깊이 이해하게 되었습니다. 또한 주사비 유병률의 증가도 예측 기간 중 전 세계 주사비 치료제 시장의 성장을 지속적으로 지원할 것으로 보입니다. 주사는 전 세계 수백만 명의 사람들에게 영향을 미치는 흔한 만성 피부 질환입니다. 혁신적인 치료법의 개발은 예측 기간 중 전 세계 주사 치료제 시장에 새로운 기회를 가져다줄 것입니다. 로사(rosacea)에 대한 완전히 새롭고 더 효과적인 치료법의 개발은 항상 요구되고 있습니다.
현재 이용 가능한 치료법의 효능이 제한적이라는 점은, 예측 기간 중 전 세계 주사 치료제 시장의 성장을 저해할 것으로 예상됩니다. 주사 치료제의 선택지는 다양하지만, 모든 환자가 만족스러운 치료 결과를 얻는 것은 아닙니다.
이 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 시장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요 인사이트도 제공하고 있습니다.
- 세계의 주사 치료제 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 이 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계의 주사 치료제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 주사 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 주사 치료제 시장 : 약제 클래스별(2021-2033년)
제5장 주사 치료제 시장 : 투여 경로별(2021-2033년)
제6장 주사 치료제 시장 : 유형별(2021-2033년)
제7장 주사 치료제 시장 : 유통 채널별(2021-2033년)
제8장 주사 치료제 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KSA 26.07.08Rosacea Treatment Market is estimated to be valued at USD 2.30 Bn in 2026 and is expected to reach USD 3.63 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.30 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.70% | 2033 Value Projection: | USD 3.63 Bn |
Rosacea is a chronic skin condition characterized by redness, flushing, and sometimes small, pus-filled bumps on the face. It can be a frustrating condition to manage but there are various treatment options available. In order to cure the symptoms of rosacea and enhance patients' quality of life, the market offers a variety of treatment choices, including topical drugs, oral medications, laser therapies, light-based treatments, and skin care products, among others. The actual etiology of rosacea is unknown, but a number of factors, including genetics, environmental triggers, and some drugs, are likely to be involved.
Market Dynamics:
Increasing recognition and diagnosis will continue to fuel the growth of the global rosacea treatment market over the forecast period. Both patients and medical professionals now have a better grasp of rosacea. Rising rosacea prevalence will also continue to fuel the growth of the global rosacea treatment market over the forecast period. A widespread chronic skin disorder that affects millions of individuals worldwide is rosacea. The creation of innovative therapies will create new opportunities for the global rosacea treatment market over the forecast period. The creation of brand-new, better treatments for rosacea is constantly needed.
Limited efficacy of available treatments is expected to hamper the growth of the global rosacea treatment market over the forecast period. Despite the fact that there are numerous rosacea treatment choices, not all patients have good outcomes.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global rosacea treatment market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Galderma, Allergan, Bayer, Foamix Pharmaceuticals, Mayne Pharma, Leo Pharma, Pfizer, Dermira, Nestle Skin Health, Aclaris Therapeutics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rosacea treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rosacea treatment market
Detailed Segmentation:
- Global Rosacea Treatment Market, By Drug Class:
- Antibiotics
- Alpha agonists
- Retinoids
- Corticosteroids
- Immunosuppressants
- Other drug classes
- Global Rosacea Treatment Market, By Route of Administration:
- Topical
- Oral
- Global Rosacea Treatment Market, By Type:
- Erythematotelangiectatic rosacea
- Papulopustular rosacea
- Ocular rosacea
- Phymatous rosacea
- Global Rosacea Treatment Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail pharmacies
- Online pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profile:
- Galderma
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Rosacea Treatment, By Drug Class
- Market Rosacea Treatment, By Route of Administration
- Market Rosacea Treatment, By Type
- Market Rosacea Treatment, By Distribution Channel
- Market Rosacea Treatment, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Rosacea Prevalence
- Limited efficacy of available treatments
- Creation of innovative therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- Pipeline Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rosacea Treatment Market, By Drug Class, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Alpha agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Immunosuppressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Other drug classes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
5. Rosacea Treatment Market, By Route of Administration, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
6. Rosacea Treatment Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Erythematotelangiectatic rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Papulopustular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Ocular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Phymatous rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
7. Rosacea Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
8. Rosacea Treatment Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Lain America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth,By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Galderma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Foamix Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mayne Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Leo Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dermira
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nestle Skin Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aclaris Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
